| Financial Year |
March 31 2023 |
| Monetary Funds |
640,845,647.02 |
| Held-for-trading Financial Assets |
9,500,000.00 |
| Notes Receivable |
58,922,854.98 |
| Accounts Receivable |
1,159,805,915.42 |
| Advances to Suppliers |
51,793,574.57 |
| Other Receivables |
9,639,803.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
411,994,827.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,604,237.49 |
| Total Current Assets |
2,697,167,666.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,357,038.04 |
| Investment Properties |
-- |
| Fixed Assetes |
784,038,197.06 |
| Under-construction Projects |
478,079,994.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
137,174,413.88 |
| R&D expenses |
-- |
| Goodwill |
262,958,113.89 |
| Long-Term Deferred and Prepaid Expenses |
14,652,957.21 |
| Deferred Income Tax Assets |
33,958,566.54 |
| Other Non-Current Assets |
51,777,624.60 |
| Sub-Total of Non-Current Assets |
1,786,622,927.83 |
| Total Assets |
4,483,790,594.76 |
| Short-Term Loans |
1,268,145,230.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
361,330,267.58 |
| Accounts Payable |
203,519,873.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,076,980.04 |
| Taxes Payable |
10,521,255.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,329,763.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,339,616.93 |
| Other Current Liabilities |
6,247,695.19 |
| Sub-Total of Current Liabilities |
1,932,057,863.69 |
| Long-term Loans |
90,061,666.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,357,051.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
129,704,862.65 |
| Total Liabilities |
2,061,762,726.34 |
| Paid-In Capital(Or Share Stock) |
951,034,969.00 |
| Capital Surplus |
813,012,989.67 |
| Surplus Reserve |
100,211,725.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
504,114,410.61 |
| Minority Stockholder's Interest |
53,653,774.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,368,374,094.41 |
| Owner's Equity（Stockholder's Equity） |
2,422,027,868.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,483,790,594.76 |
